A breakthrough in cell therapy of solid tumor by Zhifei biological joint stock company
The first indication clinical trial of c-4-29 cell preparation developed by Chongqing precision Biotechnology Co., Ltd. (precision Biology) was approved by the drug evaluation center of State Drug Administration on December 10, 2020, and the second indication clinical trial application was accepted by CDE on July 8, 2021, realizing the breakthrough of car-t cell therapy for solid tumor. The company's CD70 target is the first in China, and the product c-4-29 cell preparation under research is used for the treatment of patients with relapsed / refractory multiple myeloma or advanced / metastatic renal cell carcinoma aged 18 years or above.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
Briefing May 19, 2022 05:45 PM
· Healthcare
Shenzhen textile A: the order of line 7 is full, and the production line speed is climbing
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Mar 15, 2022 12:19 PM
Half day main capital net inflow of power equipment, non bank finance, selling banks, etc
Healthcare
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
Briefing Aug 03, 2021 11:10 AM
· Healthcare
Monitoring of main funds of star mine: Top 10 list of early trading
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
Briefing Jul 20, 2021 10:05 PM
US Senate committee to investigate the role of cryptocurrency in cyber crime
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
See more
Read next
Insight
In-depth
Insight
In-depth
Automotive · Analysis
$30 Million Lost Annually in the West, Yet Chinese Enterprises Pay No Attention
Apr 30, 2025 11:14 AM
Insight
In-depth
Technology · Analysis
Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions
Apr 25, 2025 11:24 PM
Insight
In-depth
Technology · Analysis
SAIC MAXUS Partners with Huawei Qiankun, Multiple Models to be Launched
Apr 25, 2025 08:41 PM